sodium arsenite has been researched along with Carcinoma, Anaplastic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, CY; Foo, NP; Huang, BM; Ko, CL; So, EC; Wang, CY | 1 |
| García-Carrancá, A; Menéndez, D; Miranda, E; Ostrosky-Wegman, P; Rojas, E; Salazar, AM | 1 |
| Chung, BS; Kang, CD; Kim, CM; Kim, SH; Lim, YS; Yeo, GS | 1 |
3 other study(ies) available for sodium arsenite and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Arsenic compounds activate the MAPK and caspase pathways to induce apoptosis in OEC‑M1 gingival epidermal carcinoma.
Topics: Apoptosis; Arsenites; Carcinoma; Caspases; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; G2 Phase Cell Cycle Checkpoints; Gingival Neoplasms; Humans; MAP Kinase Signaling System; Phosphorylation; Sodium Compounds | 2020 |
Induction of p53 protein expression by sodium arsenite.
Topics: Arsenites; Carcinogens; Carcinoma; Cell Division; Cell Line, Transformed; Dose-Response Relationship, Drug; Enzyme Induction; Female; Genes, p53; HeLa Cells; Herpesvirus 4, Human; Humans; Jurkat Cells; Lymphocyte Activation; Sodium Compounds; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms | 1997 |
Suppression of multidrug resistance via inhibition of heat shock factor by quercetin in MDR cells.
Topics: Animals; Antineoplastic Agents; Arsenites; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Heat-Shock Proteins; Leukemia, Experimental; Mice; Quercetin; Sodium Compounds; Tumor Cells, Cultured; Vinblastine; Vincristine | 1998 |